Related Experiment Videos

Primary immune responsiveness and other observations in mice given oral dimethyl sulfoxide

Immunopharmacology
|October 1, 1983
PubMed

Insights

Dimethyl sulfoxide (DMSO) consumption in mice led to decreased body weight and spleen size. DMSO also moderately suppressed the primary humoral immune response, impacting antibody production and immune cell activity.

Area of Science:

  • Immunology
  • Toxicology

Background:

  • Dimethyl sulfoxide (DMSO) is a widely used solvent with potential biological effects.
  • Understanding DMSO's impact on physiological and immunological parameters is crucial for its safe application.

Purpose of the Study:

  • To investigate the effects of chronic oral and acute intraperitoneal DMSO administration on mice.
  • To assess DMSO's influence on body weight, organ weight, serum volume, immunoglobulin levels, and the primary humoral immune response.

Main Methods:

  • Mice received 5% DMSO in drinking water for six weeks or 4.4 g/kg DMSO intraperitoneally for 7 days.
  • Physiological parameters (body weight, spleen weight, serum volume) and immunoglobulin concentrations were measured.
  • Humoral immune response was evaluated after sheep red blood cell immunization using plaque-forming cells and hemagglutination assays.

Main Results:

  • Chronic oral DMSO led to decreased body weight, spleen weight, and serum volume.
  • Acute intraperitoneal DMSO caused significant reductions in serum IgG and IgA.
  • DMSO exposure reduced plaque-forming cells, hemagglutination titers, and IgG1 concentrations, indicating immune suppression.

Conclusions:

  • Chronic oral DMSO administration affects body weight and spleen size.
  • DMSO demonstrably suppresses the primary humoral immune response in a dose- and time-dependent manner.
  • Further research is warranted to elucidate the specific mechanisms of DMSO-induced immunomodulation.

Related Concept Videos